Helping to share the web since 1996
Herceptin (Trastuzumab) is a monoclonal antibody drug for the treatment of breast cancer which is HER2 receptor positive. It acts via binding to HER2 receptor to suppress cell duplication.
There are no posts for this page yet.
Upgrade Options